FDA label
What is teriflunomide used for?
The FDA-approved uses of teriflunomide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted teriflunomide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Teriflunomide, tablet, film coated
Indications and Usage, quoted from the label by Teva Pharmaceuticals, Inc. (ANDA209700). Cross-references to other label sections are left out.
Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Source: DailyMed label, set id c424959d-00c9-4e76-aba6-cc7464d8e903, version 5, effective August 26, 2026. NDC 0480-3156, one of 28 listings for this product.
Questions
What is teriflunomide used for?
The FDA label says: “Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.”
What drug class is teriflunomide?
FDA lists teriflunomide in the Pyrimidine Synthesis Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Teriflunomide
- Is Teriflunomide a controlled substance?Federal schedule
- Generic for AubagioFDA Orange Book
- What is Aubagio used for?FDA label uses
- Is Aubagio a controlled substance?Federal schedule
- Pyrimidine Synthesis Inhibitors listFDA drug class
- NDC 58468-0210Teriflunomide NDC record
- NDC 58468-0211Teriflunomide NDC record
- NDC 0378-0627Teriflunomide NDC record